126 related articles for article (PubMed ID: 30016089)
1. Mechanism of Selective Enzyme Inhibition through Uncompetitive Regulation of an Allosteric Agonist.
Boulton S; Selvaratnam R; Blondeau JP; Lezoualc'h F; Melacini G
J Am Chem Soc; 2018 Aug; 140(30):9624-9637. PubMed ID: 30016089
[TBL] [Abstract][Full Text] [Related]
2. Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states.
Mazhab-Jafari MT; Das R; Fotheringham SA; SilDas S; Chowdhury S; Melacini G
J Am Chem Soc; 2007 Nov; 129(46):14482-92. PubMed ID: 17973384
[TBL] [Abstract][Full Text] [Related]
3. The auto-inhibitory role of the EPAC hinge helix as mapped by NMR.
Selvaratnam R; Mazhab-Jafari MT; Das R; Melacini G
PLoS One; 2012; 7(11):e48707. PubMed ID: 23185272
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Action of an EPAC1-Selective Competitive Partial Agonist.
Shao H; Mohamed H; Boulton S; Huang J; Wang P; Chen H; Zhou J; Luchowska-Stańska U; Jentsch NG; Armstrong AL; Magolan J; Yarwood S; Melacini G
J Med Chem; 2020 May; 63(9):4762-4775. PubMed ID: 32297742
[TBL] [Abstract][Full Text] [Related]
5. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1).
Courilleau D; Bouyssou P; Fischmeister R; Lezoualc'h F; Blondeau JP
Biochem Biophys Res Commun; 2013 Oct; 440(3):443-8. PubMed ID: 24099776
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of modulators of exchange protein activated by cAMP (Epac) activity: structure-function implications for Epac activation and inhibition.
Brown LM; Rogers KE; McCammon JA; Insel PA
J Biol Chem; 2014 Mar; 289(12):8217-30. PubMed ID: 24497631
[TBL] [Abstract][Full Text] [Related]
7. cAMP-dependent allostery and dynamics in Epac: an NMR view.
Selvaratnam R; Akimoto M; VanSchouwen B; Melacini G
Biochem Soc Trans; 2012 Feb; 40(1):219-23. PubMed ID: 22260694
[TBL] [Abstract][Full Text] [Related]
8. Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac.
Courilleau D; Bisserier M; Jullian JC; Lucas A; Bouyssou P; Fischmeister R; Blondeau JP; Lezoualc'h F
J Biol Chem; 2012 Dec; 287(53):44192-202. PubMed ID: 23139415
[TBL] [Abstract][Full Text] [Related]
9. Conformational States of Exchange Protein Directly Activated by cAMP (EPAC1) Revealed by Ensemble Modeling and Integrative Structural Biology.
White MA; Tsalkova T; Mei FC; Cheng X
Cells; 2019 Dec; 9(1):. PubMed ID: 31877746
[TBL] [Abstract][Full Text] [Related]
10. Entropy-driven cAMP-dependent allosteric control of inhibitory interactions in exchange proteins directly activated by cAMP.
Das R; Mazhab-Jafari MT; Chowdhury S; SilDas S; Selvaratnam R; Melacini G
J Biol Chem; 2008 Jul; 283(28):19691-703. PubMed ID: 18411261
[TBL] [Abstract][Full Text] [Related]
11. Dynamically driven ligand selectivity in cyclic nucleotide binding domains.
Das R; Chowdhury S; Mazhab-Jafari MT; Sildas S; Selvaratnam R; Melacini G
J Biol Chem; 2009 Aug; 284(35):23682-96. PubMed ID: 19403523
[TBL] [Abstract][Full Text] [Related]
12. Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors.
Brown LM; Rogers KE; Aroonsakool N; McCammon JA; Insel PA
J Biol Chem; 2014 Oct; 289(42):29148-57. PubMed ID: 25183009
[TBL] [Abstract][Full Text] [Related]
13. Role of dynamics in the autoinhibition and activation of the exchange protein directly activated by cyclic AMP (EPAC).
VanSchouwen B; Selvaratnam R; Fogolari F; Melacini G
J Biol Chem; 2011 Dec; 286(49):42655-42669. PubMed ID: 21873431
[TBL] [Abstract][Full Text] [Related]
14. Structural dynamics in the activation of Epac.
Harper SM; Wienk H; Wechselberger RW; Bos JL; Boelens R; Rehmann H
J Biol Chem; 2008 Mar; 283(10):6501-8. PubMed ID: 18167352
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Epac activation: structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities.
Tsalkova T; Blumenthal DK; Mei FC; White MA; Cheng X
J Biol Chem; 2009 Aug; 284(35):23644-51. PubMed ID: 19553663
[TBL] [Abstract][Full Text] [Related]
16. Isoform-specific antagonists of exchange proteins directly activated by cAMP.
Tsalkova T; Mei FC; Li S; Chepurny OG; Leech CA; Liu T; Holz GG; Woods VL; Cheng X
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18613-8. PubMed ID: 23091014
[TBL] [Abstract][Full Text] [Related]
17. Communication between the regulatory and the catalytic region of the cAMP-responsive guanine nucleotide exchange factor Epac.
Rehmann H; Rueppel A; Bos JL; Wittinghofer A
J Biol Chem; 2003 Jun; 278(26):23508-14. PubMed ID: 12707263
[TBL] [Abstract][Full Text] [Related]
18. The projection analysis of NMR chemical shifts reveals extended EPAC autoinhibition determinants.
Selvaratnam R; VanSchouwen B; Fogolari F; Mazhab-Jafari MT; Das R; Melacini G
Biophys J; 2012 Feb; 102(3):630-9. PubMed ID: 22325287
[TBL] [Abstract][Full Text] [Related]
19. Structure and regulation of the cAMP-binding domains of Epac2.
Rehmann H; Prakash B; Wolf E; Rueppel A; de Rooij J; Bos JL; Wittinghofer A
Nat Struct Biol; 2003 Jan; 10(1):26-32. PubMed ID: 12469113
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the activation of the Rap-specific exchange factor Epac by cyclic nucleotides.
Rehmann H
Methods Enzymol; 2006; 407():159-73. PubMed ID: 16757322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
